These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 30597624)

  • 1. Longitudinal tau accumulation and atrophy in aging and alzheimer disease.
    Harrison TM; La Joie R; Maass A; Baker SL; Swinnerton K; Fenton L; Mellinger TJ; Edwards L; Pham J; Miller BL; Rabinovici GD; Jagust WJ
    Ann Neurol; 2019 Feb; 85(2):229-240. PubMed ID: 30597624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
    Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
    Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.
    Zeydan B; Lowe VJ; Reichard RR; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Parisi JE; Machulda MM; Vemuri P; Mielke MM; Knopman DS; Petersen RC; Jack CR; Kantarci OH; Kantarci K
    Ann Neurol; 2020 Apr; 87(4):556-567. PubMed ID: 31970802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of
    La Joie R; Visani AV; Lesman-Segev OH; Baker SL; Edwards L; Iaccarino L; Soleimani-Meigooni DN; Mellinger T; Janabi M; Miller ZA; Perry DC; Pham J; Strom A; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Neurology; 2021 Feb; 96(5):e650-e661. PubMed ID: 33262228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults.
    Harrison TM; Du R; Klencklen G; Baker SL; Jagust WJ
    Alzheimers Dement; 2021 Jul; 17(7):1085-1096. PubMed ID: 33325068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tau accumulation and atrophy in mild cognitive impairment: a longitudinal study.
    Xu G; Zheng S; Zhu Z; Yu X; Jiang J; Jiang J; Chu Z;
    Ann Nucl Med; 2020 Nov; 34(11):815-823. PubMed ID: 32785820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
    Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy.
    Lesman-Segev OH; La Joie R; Stephens ML; Sonni I; Tsai R; Bourakova V; Visani AV; Edwards L; O'Neil JP; Baker SL; Gardner RC; Janabi M; Chaudhary K; Perry DC; Kramer JH; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2019; 24():102025. PubMed ID: 31670152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
    Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
    Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.
    Sintini I; Martin PR; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Spychalla AJ; Drubach DA; Knopman DS; Petersen RC; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Neuroimage Clin; 2019; 23():101823. PubMed ID: 31004914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults.
    Denkinger M; Baker S; Inglis B; Kobayashi S; Juarez A; Mason S; Jagust W
    PLoS One; 2024; 19(6):e0299764. PubMed ID: 38837947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.
    Das SR; Xie L; Wisse LEM; Ittyerah R; Tustison NJ; Dickerson BC; Yushkevich PA; Wolk DA;
    Neurobiol Aging; 2018 Jun; 66():49-58. PubMed ID: 29518752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults.
    McSweeney M; Pichet Binette A; Meyer PF; Gonneaud J; Bedetti C; Ozlen H; Labonté A; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
    Neurology; 2020 Mar; 94(11):e1190-e1200. PubMed ID: 32015176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid and tau PET demonstrate region-specific associations in normal older people.
    Lockhart SN; Schöll M; Baker SL; Ayakta N; Swinnerton KN; Bell RK; Mellinger TJ; Shah VD; O'Neil JP; Janabi M; Jagust WJ
    Neuroimage; 2017 Apr; 150():191-199. PubMed ID: 28232190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
    Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.